TOG Review (RCOG Journal)
MRCOG Part 2
Subfertility and Reproductive Medicine
An update on the management of male infertility
Key Statistics
- 1 in 7 — UK couples subfertile
- 50% — Cases with male factor
- 25–30% — Live birth rate/ICSI cycle
Don't-miss facts
-
Male factor contributes to up to 50% of infertility cases (1 in 7 UK couples affected); ICSI remains mainstay treatment as no medical/surgical treatment reliably improves sperm quality (except hypogonadotrophic hypogonadism)
-
WHO semen reference limits: volume 1.5 ml, concentration 15×10⁶/ml, total motility 40%, progressive motility 32%, normal forms 4%
-
Antioxidants (2019 Cochrane): live birth OR 1.79, clinical pregnancy OR 2.97 – but low-quality evidence from small trials
-
PICSI RCT (n=2772): no live birth benefit over conventional ICSI – not recommended routinely
-
AZFc deletion = good prognosis (testicular sperm extraction feasible); AZFa/AZFb deletion = very poor prognosis, retrieval not recommended
-
Klinefelter syndrome (47,XXY) found in 11% of azoospermic men – commonest karyotype abnormality
-
Routine genetic tests (karyotype + Y-microdeletion + CFTR) explain aetiology in only 20% of infertile men
-
SDF testing not recommended routinely in ART work-up or to predict miscarriage – no proven treatment for high SDF
Evidence tiers at a glance
Recommended: SA to WHO standard, karyotype/AZF/CFTR in severe oligo-/azoospermia, ICSI
Not recommended routinely: PICSI, MSOME/IMSI, MACS, routine SDF testing, FISH sperm aneuploidy screening
Abbreviation Key
- ART — assisted reproductive technology
- RR — risk ratio
- ICSI — intracytoplasmic sperm injection
- CI — confidence interval
- IVF — in vitro fertilisation
- RCT — randomised controlled trial
- HFEA — Human Fertilisation and Embryology Authority
- MSOME — motile sperm organelle morphology evaluation
- WHO — World Health Organization
- IMSI — intracytoplasmic morphologically selected sperm injection
- SA — semen analysis
- PICSI — physiological ICSI
- SDF — sperm DNA fragmentation
- HOS — hypo-osmotic swelling (test)
- SCSA — sperm chromatin structure assay
- PDEI — phosphodiesterase inhibitor
- SCD — sperm chromatin dispersion (test)
- MACS — magnetic-activated cell sorting
- TUNEL — terminal deoxynucleotidyl transferase dUTP nick end-
- FISH — fluorescence in situ hybridisation labelling
- CFTR — cystic fibrosis transmembrane conductance regulator
- COMET — single cell gel electrophoresis assay
- CBAVD — congenital bilateral absence of the vas deferens
- OS — oxidative stress
- AZF — azoospermia factor (region, Y chromosome)
- OR — odds ratio
Source: Karavolos S, Panagiotopoulou N et al. An update on the management of male infertility. The Obstetrician & Gynaecologist 2020;22:267–274. doi:10.1111/tog.12688
MRCOG AI is an independent educational tool. It is not affiliated with, endorsed by, or connected to the Royal College of Obstetricians and Gynaecologists (RCOG).